Why Digital Storage Inflation Will Accelerate Seagate’s Growth Beyond The Next 3 Years9 December 2024
Storm Darragh chaos goes on as 38 red flood alerts in place across UK – check your area9 December 2024
Cheapest Coldplay Wembley Stadium and Hull tickets still available to buy as Christmas gifts9 December 2024
China Medical System: First Prescriptions for Innovative Drug Lumeblue® Issued in China9 December 2024
Powering Canada’s Future: Ensuring Access to Affordable, Reliable and Clean Electricity in New Brunswick Business 8 December 2024 DIEPPE, NB, Dec. 8, 2024 /CNW/ – In the 21st century, a reliable and affordable clean electricity grid is the…
Investigational Epcoritamab (DuoBody® CD3xCD20) Monotherapy Achieves High Overall and Complete Response Rates in Clinical Trial of Patients With Relapsed or Refractory (R/R) Chronic Lymphocytic Leukemia (CLL) in Preliminary Analysis Business 8 December 2024 COPENHAGEN, Denmark–(BUSINESS WIRE)–Dec 8, 2024–Genmab A/S (Nasdaq: GMAB):Preliminary analyses from the EPCORE ® CLL-1 trial demonstrates overall response rate (ORR)…
Mesmerize Software Studio Announces Innovative Solutions to Redefine Business Technology Business 8 December 2024 Mesmerize Software Studio unveils a transformative approach to technology, blending art and innovation to deliver personalized, captivating, and high-performing digital…
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Match Group, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – MTCH Business 8 December 2024 NEW YORK, Dec. 08, 2024 (GLOBE NEWSWIRE) –WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of…
University of Nebraska Wins the Abbott and Big Ten Conference’s Nationwide ‘We Give Blood Drive’ Competition, Receives $1 Million Grant from Abbott Business 8 December 2024 Nearly 20,000 Big Ten students, alumni and fans across the country donated blood as part of the Abbott-Big Ten nationwide…
Global Times: Clay Figure Zhang’s works naturally reflect spiritual state of the times Business 8 December 2024 BEIJING, Dec. 7, 2024 /PRNewswire/ — From exquisite craftsmanship to traditional Chinese medicine, from solemn rituals to vibrant folk art,…
Adaptive Biotechnologies Announces New Data at the 66th ASH Annual Meeting Highlighting Advances in MRD Testing with clonoSEQ® and Its Impact on Blood Cancer Treatment Decisions Business 8 December 2024 New data demonstrate the actionability of clonoSEQ for tailoring treatment decisions in patients with MCL, CLL, MM and ALLStudies show…
Novel Combination of Pozelimab and Cemdisiran (Poze-Cemdi) Achieved Greater Control of Intravascular Hemolysis in Patients with Paroxysmal Nocturnal Hemoglobinuria Compared to Ravulizumab Business 8 December 2024 Head-to-head exploratory cohort of a Phase 3 trial showed first-in-class poze-cemdi combination treatment helped patients achieve and maintain greater disease…
Syndax Presents Positive Revuforj® (revumenib) Data in Acute Leukemias from Multiple Trials, Including the SAVE Combination and AUGMENT-101 Trials, at 66th ASH Annual Meeting Business 8 December 2024 – 82% ORR (27 of 33 pts) and 48% CR/CRh (16 of 33 pts) in SAVE trial studying revumenib in…
Investigational Epcoritamab (DuoBody® CD3xCD20) Combination Therapy Demonstrates High Response Rates in Clinical Trial of Patients With Relapsed or Refractory (R/R) Follicular Lymphoma (FL) Business 8 December 2024 COPENHAGEN, Denmark–(BUSINESS WIRE)–Dec 7, 2024–Genmab A/S (Nasdaq: GMAB):Results show 96 percent overall response rate (ORR), 87 percent complete response (CR),…
